Patients Say GSK Lyme Disease Vaccine Caused Arthritis

Law360, New York (August 8, 2012, 3:43 PM EDT) -- In a pair of suits removed to Pennsylvania federal court by GlaxoSmithKline LLC on Tuesday, two plaintiffs allege the pharmaceutical company's Lyme disease vaccine LYMERix caused treatment-resistant Lyme arthritis.

According to the complaint, the plaintiffs, who were inoculated with LYMERix in the late 1990s, were later diagnosed with post-Lyme disease treatment syndrome or treatment-resistant Lyme arthritis. The complaint said that patients with a certain genetic blood trait are more likely to develop the condition. The suits allege that GSK, which first began selling LYMERix in 1998,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.